Here's a heartening article about a coalition that has just completed negotiations which will permit antimalarial medication to be sold in five Nigerian states (together containing about one-fifth of the population) for as little as N60.00 per dose (that's about 27 cents). Previously, Artemisinin-based Combination Therapies had sold for anywhere between N800.00 and N2000.00. The Partnership for Transforming Health Systems, PATHS2, is a program of the United Kingdom Department for International Development. The initiative is a collaboration of PATHS2 with the Clinton Health Access Initiative, Nigeria's Federal Ministry of Health, and some pharmaceutical manufacturing firms, working through the Affordable Medicines Facility for malaria (AMFm) initiative. More details on the funding mechanism are here. Malaria accounts for 70% of all disease incidence in Nigeria; in 2008 there were 57,506,430 reported cases, of which 225,424 were fatal.